Blood test may spot hidden gut trouble in kids with rare disease
NCT ID NCT07664228
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether a protein in the blood, called I-FABP, can tell doctors if a child's IgA vasculitis is affecting their stomach or intestines. Researchers will take blood samples from 100 children at diagnosis and again 2-4 weeks later. If I-FABP levels are linked to gut symptoms, it could become a simple tool to guide treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple blood test that helps doctors quickly identify which children with IgA vasculitis have gut involvement, allowing for earlier treatment.
- What could go wrong
- This is a small, early observational study, not a treatment trial. The blood marker may not prove accurate enough for routine use, and results may not apply to all children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL INVOLVEMENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bursa City Hospital
RECRUITINGBursa, Bursa, 16250, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New combo therapy aims to tame rare blood vessel disease
- Pregnancy and vasculitis: new study seeks answers
- Skin biopsies shed light on rare blood vessel disease
- New hope for kids with rare kidney disease: telitacicept vs. steroids
- Which drug tames skin vasculitis best? new trial aims to find out
- Scientists build tissue bank to unlock vasculitis mysteries